|
1
|
Nonoperative management of primary colorectal cancer in patients with stage IV disease.
|
Ann Surg Oncol
|
1999
|
2.61
|
|
2
|
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial.
|
Ann Oncol
|
2013
|
1.62
|
|
3
|
Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer.
|
Ann Oncol
|
2011
|
1.11
|
|
4
|
Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma.
|
Am J Surg
|
1999
|
1.08
|
|
5
|
Activity of multitargeted antifolate (pemetrexed disodium, LY231514) in patients with advanced colorectal carcinoma: results from a phase II study.
|
Cancer
|
2000
|
1.06
|
|
6
|
A USA registry of gastrointestinal stromal tumor patients: changes in practice over time and differences between community and academic practices.
|
Ann Oncol
|
2011
|
0.96
|
|
7
|
Prognosis of adenocarcinoma arising in Barrett's esophagus.
|
Ann Thorac Surg
|
1998
|
0.79
|
|
8
|
Integrated analysis of overall survival in two randomised studies comparing 5-fluorouracil/leucovorin with or without trimetrexate in advanced colorectal cancer.
|
Ann Oncol
|
2002
|
0.78
|
|
9
|
Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030).
|
Br J Cancer
|
2013
|
0.78
|
|
10
|
Nursing care strategies for the management of side effects in patients treated for colorectal cancer.
|
Semin Oncol
|
1997
|
0.78
|
|
11
|
Topoisomerase I inhibitors in the treatment of colorectal cancer.
|
Semin Oncol
|
1999
|
0.77
|
|
12
|
Panitumumab monotherapy compared with cetuximab and irinotecan combination therapy in patients with previously treated KRAS wild-type metastatic colorectal cancer.
|
Curr Oncol
|
2013
|
0.76
|